ASSURE - ABATACEPT STUDY OF SAFETY IN USE WITH OTHER RA THERAPIES Trademark

Trademark Overview

On Tuesday, May 11, 2004, a trademark application was filed for ASSURE - ABATACEPT STUDY OF SAFETY IN USE WITH OTHER RA THERAPIES with the United States Patent and Trademark Office. The USPTO has given the ASSURE - ABATACEPT STUDY OF SAFETY IN USE WITH OTHER RA THERAPIES trademark a serial number of 78416533. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, August 19, 2009. This trademark is owned by Bristol-Myers Squibb Company. The ASSURE - ABATACEPT STUDY OF SAFETY IN USE WITH OTHER RA THERAPIES trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Clinical trials relating to pharmaceutical preparations for human use
assure - abatacept study of safety in use with other ra therapies

General Information

Serial Number78416533
Word MarkASSURE - ABATACEPT STUDY OF SAFETY IN USE WITH OTHER RA THERAPIES
Filing DateTuesday, May 11, 2004
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, August 19, 2009
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 11, 2005

Trademark Statements

Disclaimer with Predetermined Text"ABATACEPT STUDY OF SAFETY IN USE WITH OTHER RA THERAPIES"
Goods and ServicesClinical trials relating to pharmaceutical preparations for human use

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, May 18, 2004
Primary Code042
First Use Anywhere DateWednesday, February 15, 2006
First Use In Commerce DateWednesday, February 15, 2006

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10154
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Wednesday, August 19, 2009ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, August 19, 2009ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, January 15, 2009NON-FINAL ACTION MAILED
Thursday, January 15, 2009SU - NON-FINAL ACTION - WRITTEN
Tuesday, January 6, 2009STATEMENT OF USE PROCESSING COMPLETE
Wednesday, December 17, 2008USE AMENDMENT FILED
Tuesday, January 6, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 17, 2008TEAS STATEMENT OF USE RECEIVED
Tuesday, June 17, 2008EXTENSION 5 GRANTED
Tuesday, June 17, 2008EXTENSION 5 FILED
Tuesday, June 17, 2008TEAS EXTENSION RECEIVED
Monday, December 10, 2007EXTENSION 4 GRANTED
Monday, December 10, 2007EXTENSION 4 FILED
Monday, December 10, 2007TEAS EXTENSION RECEIVED
Thursday, June 14, 2007EXTENSION 3 GRANTED
Thursday, June 14, 2007EXTENSION 3 FILED
Thursday, June 14, 2007TEAS EXTENSION RECEIVED
Friday, December 22, 2006EXTENSION 2 GRANTED
Friday, December 22, 2006EXTENSION 2 FILED
Friday, December 22, 2006TEAS EXTENSION RECEIVED
Tuesday, April 25, 2006EXTENSION 1 GRANTED
Tuesday, April 25, 2006EXTENSION 1 FILED
Tuesday, April 25, 2006TEAS EXTENSION RECEIVED
Tuesday, January 3, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 11, 2005PUBLISHED FOR OPPOSITION
Wednesday, September 21, 2005NOTICE OF PUBLICATION
Sunday, June 26, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Sunday, June 26, 2005ASSIGNED TO LIE
Friday, June 24, 2005ASSIGNED TO LIE
Saturday, June 11, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 25, 2005TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 10, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 10, 2005TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 13, 2004NON-FINAL ACTION MAILED
Saturday, December 11, 2004NON-FINAL ACTION WRITTEN
Thursday, December 9, 2004ASSIGNED TO EXAMINER
Tuesday, May 18, 2004NEW APPLICATION ENTERED IN TRAM

Related Keywords

other therapies safety study abatacept assure preparations human pharmaceutical relating trials clinical